| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_728de25d2417e186a503223946e717a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9972272cf7703268651bed5b0d205f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b0f66ded9b00e199be987b856be0f21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dfd7a0615bdd93dbc212cc731f4787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a00950ad680c4dce3e1788715cd04f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0515 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-00 |
| filingDate |
2008-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf252dd41c2fe26a1c6ade694636f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56d4ab91451df600b3e4e94ae5395f65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef81d46a790e30a2b9c5f004a8126e78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17e40fe6bb1eb7db2134471667ef7758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d20c2d6ef97200d42bb84b77e44d9cc4 |
| publicationDate |
2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8195275-B2 |
| titleOfInvention |
Vessel size imaging for antiangiogenic therapy |
| abstract |
A system and method of evaluating the effectiveness of antiangionetic therapy is described. A patient or test animal is treated with an antiangionetic substance. Magnetic resonance imaging data is obtained prior to and subsequent to the treatment. The parameters of the imaging process are configured so that, by administering a intravascular contrast agent, the relative size of the microvascular and the total vascular volumes in a region of interest may be obtained, so as to form a vascular size index. The value of the vascular size index and other pharmacokinetic data obtained by the administration of a diffusible contrast agent are used to assess the efficacy of the treatment or the antiangionetic substance being studied. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015050218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8452065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298692-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011262017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8422756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012283546-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3404437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010232667-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107851297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010254584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8693761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9952300-B2 |
| priorityDate |
2007-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |